SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, ...

Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product ...

SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine, has obtained a patent from the U.S. Patent and Trademark Office for its ...

A DNA-based blood test appears to be more effective in detecting possible Down syndrome in fetuses than standard screening methods for the genetic disorder, researchers say. The test exhibited perfect ...

Scanning fetal DNA from a blood test will be "without question a major medical advance that promises to greatly improve current prenatal care," says Jaime King, an associate professor at the ...